Michael Dworzak Selected Research

ICE protocol 4

8/2015	Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial.
1/2014	Development of treatment and clinical results in childhood AML in Austria (1993-2013).
1/2012	The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study.
5/2010	Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse.
9/2006	Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
11/2004	Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Dworzak Research Topics

Disease

14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 11/2004
14	Neoplasms (Cancer) 01/2021 - 10/2002
8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2020 - 12/2002
7	Leukemia 01/2021 - 01/2010
5	Infections 01/2019 - 11/2004
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2017 - 03/2011
3	Neutropenia 01/2017 - 09/2006
3	Juvenile Myelomonocytic Leukemia 04/2015 - 09/2014
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 04/2006 - 12/2002
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021 - 10/2020
2	Mycoses (Diseases, Fungus) 01/2021 - 01/2017
2	Febrile Neutropenia 01/2017 - 02/2007
2	Down Syndrome (Down's Syndrome) 01/2017 - 08/2015
2	Disease Progression 08/2012 - 03/2011
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2010 - 12/2002
2	Lymphoma (Lymphomas) 04/2006 - 12/2002
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2005 - 12/2002
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Fever (Fevers) 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2021
1	Appendicitis 01/2021
1	Viremia 01/2021
1	GATA2 Deficiency 10/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2020
1	Bacteremia 01/2019
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2017
1	Sepsis (Septicemia) 01/2017
1	Aplastic Anemia (Anemia, Hypoplastic) 03/2016
1	Cytopenia 04/2014
1	Headache (Headaches) 07/2013
1	Diarrhea 07/2013
1	Nausea 07/2013
1	Philadelphia Chromosome 07/2013
1	Vomiting 07/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2012
1	Cardiotoxicity 05/2010
1	Pathologic Complete Response 01/2010
1	Liver Diseases (Liver Disease) 03/2008
1	Thrombocytopenia (Thrombopenia) 03/2008
1	Lung Diseases (Lung Disease) 02/2008
1	Hodgkin Disease (Hodgkin's Disease) 12/2007
1	B-Cell Leukemia (Leukemia, B Cell) 01/2005
1	Residual Neoplasm 02/2002

Drug/Important Bio-Agent (IBA)

3	Imatinib Mesylate (Gleevec)FDA Link 10/2017 - 03/2011
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2010 - 09/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2017 - 07/2013
2	Biological ProductsIBA 12/2016 - 10/2013
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 03/2011
1	Retinoic Acid Receptor alphaIBA 10/2021
1	ChromatinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 10/2020
1	GATA2 Transcription FactorIBA 10/2020
1	Factor XIII (Coagulation Factor XIII)IBA 08/2020
1	Cisplatin (Platino)FDA LinkGeneric 03/2020
1	BI 6727IBA 10/2019
1	Gemtuzumab (Mylotarg)FDA Link 01/2019
1	alanyl-leucyl-alanyl-leucine (ALAL)IBA 01/2018
1	TeicoplaninIBA 01/2017
1	Vancomycin FDA LinkGeneric 01/2017
1	Coloring Agents (Dyes)IBA 12/2016
1	Azacitidine (5 Azacytidine)FDA Link 04/2015
1	DNA (Deoxyribonucleic Acid)IBA 09/2014
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 04/2014
1	thymoglobulin FDA Link 04/2014
1	Dasatinib (BMS 354825)FDA Link 07/2013
1	Daunorubicin (Cerubidine)FDA LinkGeneric 02/2013
1	Messenger RNA (mRNA)IBA 03/2011
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 05/2010
1	Protein Isoforms (Isoforms)IBA 05/2010
1	AnthracyclinesIBA 05/2010
1	Peroxidase (Myeloperoxidase)IBA 01/2010
1	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2008
1	GlucocorticoidsIBA 12/2007
1	Genetic Markers (Genetic Marker)IBA 12/2007
1	Anaplastic Lymphoma KinaseIBA 04/2006
1	Oxidoreductases (Dehydrogenase)IBA 12/2002

Therapy/Procedure

17	Therapeutics 05/2021 - 02/2002
8	Drug Therapy (Chemotherapy) 01/2021 - 12/2002
6	ICE protocol 4 08/2015 - 11/2004
4	Hematopoietic Stem Cell Transplantation 11/2021 - 08/2012
3	Stem Cell Transplantation 01/2021 - 02/2008
2	Transplantation 10/2021 - 01/2015
2	Combination Drug Therapy (Combination Chemotherapy) 03/2020 - 08/2011
1	Organ Transplantation 10/2021
1	Appendectomy 01/2021
1	Salvage Therapy 01/2019
1	Antibiotic Prophylaxis 01/2017
1	Investigational Therapies (Experimental Therapy) 07/2013
1	Radiotherapy 12/2002
1	Operative Surgical Procedures 10/2002